The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to verify the role of adding cisplatin chemotherapy to the
intensity-modulated radiotherapy (IMRT) for stage II nasopharyngeal carcinoma.